glp-1 adoption New Demand in an Old Market GLP-1 Receptor Agonist Market Forecast

Retatrutide trials excluded pregnant and breastfeeding individuals

The FDA notes it has collected reports of compounded GLP-1s not being refrigerated adequately or being made with poor-quality ingredients

Before this past spring, many compounding pharmacies were selling copycat versions of GLP-1s, which the FDA permits if a drug is in shortage

doi: 10.1016/S0140-6736(18)32260-8 67 FriasJPNauckMAVanJBensonCBrayRCuiXet al

however, clinical trials assessing the efficacy of oral semaglutide (Rybelsus) in obesity are still enrolling participants (NCT05442450)

Based on similar medications like Zepbound, if you miss a dose, you may be instructed to take it as soon as possible within 4 days